GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Shares Buyback Ratio %

Hisamitsu Pharmaceutical Co (TSE:4530) Shares Buyback Ratio % : 2.57 (As of May. 17, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Hisamitsu Pharmaceutical Co's current shares buyback ratio was 2.57%.


Hisamitsu Pharmaceutical Co Shares Buyback Ratio % Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Shares Buyback Ratio % Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 -0.09 2.44 2.50 2.57

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.24 - 0.32 1.29 0.98

Hisamitsu Pharmaceutical Co Shares Buyback Ratio % Calculation

Hisamitsu Pharmaceutical Co's Shares Buyback Ratio for the fiscal year that ended in Feb. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Feb. 2023 ) - Shares Outstanding (EOP) (A: Feb. 2024 )) / Shares Outstanding (EOP) (A: Feb. 2023 )
=(77.7443 - 75.7431) / 77.7443
=2.57%

Hisamitsu Pharmaceutical Co's Shares Buyback Ratio for the quarter that ended in Nov. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Aug. 2023 ) - Shares Outstanding (EOP) (A: Nov. 2023 )) / Shares Outstanding (EOP) (A: Aug. 2023 )
=(77.4955 - 76.4943) / 77.4955
=1.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines